» Articles » PMID: 33437165

Ginsenosides Rk1 and Rg5 Inhibit Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition and Suppress Migration, Invasion, Anoikis Resistance, and Development of Stem-like Features in Lung Cancer

Overview
Journal J Ginseng Res
Date 2021 Jan 13
PMID 33437165
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lung cancer has a high incidence worldwide, and most lung cancer-associated deaths are attributable to cancer metastasis. Although several medicinal properties of Meyer have been reported, the effect of ginsenosides Rk1 and Rg5 on epithelial-mesenchymal transition (EMT) stimulated by transforming growth factor beta 1 (TGF- β1) and self-renewal in A549 cells is relatively unknown.

Methods: We treated TGF-β1 or alternatively Rk1 and Rg5 in A549 cells. We used western blot analysis, real-time polymerase chain reaction (qPCR), wound healing assay, Matrigel invasion assay, and anoikis assays to determine the effect of Rk1 and Rg5 on TGF-mediated EMT in lung cancer cell. In addition, we performed tumorsphere formation assays and real-time PCR to evaluate the stem-like properties.

Results: EMT is induced by TGF-β1 in A549 cells causing the development of cancer stem-like features. Expression of E-cadherin, an epithelial marker, decreased and an increase in vimentin expression was noted. Cell mobility, invasiveness, and anoikis resistance were enhanced with TGF-β1 treatment. In addition, the expression of stem cell markers, CD44, and CD133, was also increased. Treatment with Rk1 and Rg5 suppressed EMT by TGF-β1 and the development of stemness in a dose-dependent manner. Additionally, Rk1 and Rg5 markedly suppressed TGF-β1-induced metalloproteinase-2/9 (MMP2/9) activity, and activation of Smad2/3 and nuclear factor kappa B/extra-cellular signal regulated kinases (NF-kB/ERK) pathways in lung cancer cells.

Conclusions: Rk1 and Rg5 regulate the EMT inducing TGF-β1 by suppressing the Smad and NF-κB/ERK pathways (non-Smad pathway).

Citing Articles

Metabolic reprogramming and signaling adaptations in anoikis resistance: mechanisms and therapeutic targets.

He C, He J Mol Cell Biochem. 2025; .

PMID: 39821582 DOI: 10.1007/s11010-024-05199-3.


An anoikis-related gene signature predicts prognosis in patients with acute myeloid leukemia and immunotherapy.

Xu R, Du A, Li J, Yang Q Am J Cancer Res. 2024; 14(11):5116-5132.

PMID: 39659934 PMC: 11626272. DOI: 10.62347/MJTA2660.


Identification and validation of a novel prognostic model based on anoikis‑related genes in acute myeloid leukemia.

Chen Y, Luo W, Hu M, Yao X, Wang J, Huang Y Oncol Lett. 2024; 29(1):62.

PMID: 39611065 PMC: 11602830. DOI: 10.3892/ol.2024.14808.


Identification of anoikis-related long non-coding RNA signature as a novel prognostic model in lung adenocarcinoma.

Fang X, Wei M, Liu X, Lu L, Liu G Transl Cancer Res. 2024; 13(10):5458-5472.

PMID: 39525036 PMC: 11543027. DOI: 10.21037/tcr-24-264.


Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: A systematic review.

Kim Y, Cho I, Cho S J Ginseng Res. 2024; 48(5):437-448.

PMID: 39263306 PMC: 11385392. DOI: 10.1016/j.jgr.2024.05.006.


References
1.
Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View

2.
Feng H, Lu J, Wang Y, Pei L, Chen X . Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells. Cell Adh Migr. 2017; 11(5-6):464-475. PMC: 5810511. DOI: 10.1080/19336918.2016.1259058. View

3.
Asiedu M, Ingle J, Behrens M, Radisky D, Knutson K . TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011; 71(13):4707-19. PMC: 3129359. DOI: 10.1158/0008-5472.CAN-10-4554. View

4.
Stetler-Stevenson W, Aznavoorian S, Liotta L . Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993; 9:541-73. DOI: 10.1146/annurev.cb.09.110193.002545. View

5.
Sehgal I, Thompson T . Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell. 1999; 10(2):407-16. PMC: 25177. DOI: 10.1091/mbc.10.2.407. View